Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice
Journal Article
·
· Cancer Res.; (United States)
OSTI ID:5970567
Polar solvents, which induce differentiation in murine and human tumor cells, enhance the effect of ionizing radiation on cultured mouse mammary and human colon cancer cells. To determine whether this enhancement occurs in vivo, DLD-2 human colon carcinoma xenografts in nude mice were treated with combinations of 6 MV photon irradiation, the polar solvent N-methylformamide (NMF), or combinations of the two agents. Nude mice bearing 300-mg s.c. implants of DLD-2 tumors were treated i.p. with 150 mg NMF/kg daily for 19 days. Local tumor irradiations were administered as graded single doses or as fractionated doses, daily for 4 days, following the third NMF injection. The growth-inhibiting effect of the radiation treatment for both single dose and fractionation protocols was enhanced by the polar solvent. NMF alone increased the time required for a doubling of initial tumor volume by 1.7 days, compared to control tumors. Initial tumor volume doubling times compared to untreated controls were increased by 3.6 and 7.6 days by photon doses of 10.0 and 13.75 Gy, respectively, whereas NMF plus 10.0 or 13.75 Gy increased the DLD-2 regrowth delay time by 7.5 or 12.9 days. NMF caused essentially equivalent enhancements, whether split-dose schedules of 2.5 Gy daily for 4 days, and 3.44 Gy daily for 4 days, or single doses of 10.0 and 13.75 Gy were used; therefore, radiation enhancement was not due to effects on sublethal damage repair. The results support the use of NMF, currently in Phase 1-Phase 2 clinical trials, with radiation in the therapy of selected human neoplasms.
- Research Organization:
- Rhode Island Hospital, Providence
- OSTI ID:
- 5970567
- Journal Information:
- Cancer Res.; (United States), Journal Name: Cancer Res.; (United States) Vol. 44:11; ISSN CNREA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Effect of N-methylformamide on radiocurability of murine tumors
Modification of the hypoxic fraction of a xenografted human colon tumor by differentiation-inducing agents
N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer
Journal Article
·
Thu Dec 31 23:00:00 EST 1987
· Radiat. Res.; (United States)
·
OSTI ID:5379927
Modification of the hypoxic fraction of a xenografted human colon tumor by differentiation-inducing agents
Journal Article
·
Wed May 18 00:00:00 EDT 1988
· JNCI, J. Natl. Cancer Inst.; (United States)
·
OSTI ID:6993715
N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer
Journal Article
·
Sun May 01 00:00:00 EDT 1988
· J. Clin. Oncol.; (United States)
·
OSTI ID:6936746
Related Subjects
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
AMIDES
ANIMALS
BODY
CARCINOMAS
CELL DIFFERENTIATION
DIGESTIVE SYSTEM
DISEASES
DOSES
FORMAMIDE
GASTROINTESTINAL TRACT
IN VIVO
INTESTINES
IONIZING RADIATIONS
LARGE INTESTINE
MAMMALS
MAN
MEDICINE
MICE
NEOPLASMS
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
PRIMATES
RADIATION DOSES
RADIATIONS
RADIOLOGY
RADIOSENSITIVITY EFFECTS
RADIOTHERAPY
RODENTS
SYNERGISM
THERAPY
TRANSPLANTS
VERTEBRATES
62 RADIOLOGY AND NUCLEAR MEDICINE
AMIDES
ANIMALS
BODY
CARCINOMAS
CELL DIFFERENTIATION
DIGESTIVE SYSTEM
DISEASES
DOSES
FORMAMIDE
GASTROINTESTINAL TRACT
IN VIVO
INTESTINES
IONIZING RADIATIONS
LARGE INTESTINE
MAMMALS
MAN
MEDICINE
MICE
NEOPLASMS
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
PRIMATES
RADIATION DOSES
RADIATIONS
RADIOLOGY
RADIOSENSITIVITY EFFECTS
RADIOTHERAPY
RODENTS
SYNERGISM
THERAPY
TRANSPLANTS
VERTEBRATES